Article Information
History
- March 13, 2017.
Article Versions
- You are currently viewing Version 1 of this article (March 13, 2017 - 08:05).
- Version 2 (September 29, 2017 - 08:09).
- View Version 3, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Kylie A. Beattie1,2,
- Adam P. Hill3,4,
- Rémi Bardenet5,
- Yi Cui6,
- Jamie I. Vandenberg3,4,
- David J. Gavaghan1,
- Teun P. de Boer7 and
- Gary R. Mirams1,8
- 1Computational Biology, Department of Computer Science, University of Oxford, OX1 3QD, UK
- 2Division of Applied Regulatory Science, Office of Clinical Pharmacology, Office of Translational Sciences, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD, USA
- 3Department of Molecular Cardiology and Biophysics, Victor Chang Cardiac Research Institute, Sydney, NSW 2010, Australia
- 4St Vincent’s Clinical School, UNSW Sydney, Darlinghurst, NSW 2010, Australia
- 5CNRS & CRIStAL, Université de Lille, 59651 Villeneuve d’Ascq, France
- 6Safety Evaluation and Risk Management, Global Clinical Safety and Pharmacovigilance, GlaxoSmithKline, Uxbridge, UB11 1BS, UK
- 7Division of Heart & Lungs, Department of Medical Physiology, University Medical Center Utrecht, Utrecht, The Netherlands
- 8Centre for Mathematical Medicine & Biology, School of Mathematical Sciences, University of Nottingham, NG7 2RD, UK